13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569064
Total reported value
$5.5B
$5.5B
93 檔
26.2%
According to the latest 13F quarterly dataset, Montanova Capital, LLC managed an equity portfolio of $5.5B at the end of Q4 2025, spanning 93 distinct U.S. exchange-listed positions.
In Q4 2025, Montanova Capital, LLC displayed an active expansion posture, initiating 15 new positions and adding to 25 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 11.17% | +7.16% | — | |
| 2 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 7.12% | -1.46% | +14.18% | |
| 3 | ARKG | Ark Genomic Revolution ETF | ETF-Other | 4.95% | — | — | |
| 4 | BNTC | Benitec Biopharma Inc | Stock-Other | 3.19% | -0.31% | +16.93% | |
| 5 | LEGN | Legend Biotech Corp-adr | Stock-Other | 2.94% | +0.23% | +73.09% | |
| 6 | EYPT | Eyepoint Inc | Stock-Other | 2.93% | -0.56% | +26.40% | |
| 7 | RCUS | Arcus Biosciences Inc | Stock-Other | 2.53% | -0.09% | +40.66% | |
| 8 | ✓ | Immatics NV | Stock-Other | 2.41% | -0.74% | -6.98% | |
| 9 | BHVN | Biohaven Ltd. | Stock-Other | 2.38% | +0.58% | +83.03% | |
| 10 | META | Meta Platforms Inc-class A | Stock-Comm Services | 2.29% | -0.67% | -1.11% | |
| 11 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 2.13% | -3.62% | EXIT | |
| 12 | NVDA | Nvidia CORP | Stock-Tech | 2.03% | +0.08% | +9.80% | |
| 13 | KO | Coca-cola Co/the | Stock-Consumer Staples | 1.98% | — | -4.97% | |
| 14 | GE | General Electric | Stock-Industrials | 1.96% | -0.13% | — | |
| 15 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.92% | -0.46% | +85.84% | |
| 16 | PVLA | Palvella Therapeutics Inc | Stock-Other | 1.91% | -0.50% | +8.51% | |
| 17 | KURA | Kura Oncology Inc | Stock-Other | 1.83% | -0.06% | +5.66% | |
| 18 | BAC | Bank Of America CORP | Stock-Financials | 1.71% | -0.79% | +30.79% | |
| 19 | AMD | Advanced Micro Devices | Stock-Tech | 1.71% | +1.39% | -2.31% | |
| 20 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 1.70% | — | — | |
| 21 | HD | Home Depot Inc | Stock-Consumer Disc | 1.70% | -0.40% | +22.07% | |
| 22 | AVBP | Arrivent Biopharma Inc | Stock-Other | 1.69% | +0.28% | +10.87% | |
| 23 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 1.69% | +0.08% | -2.09% | |
| 24 | SYY | Sysco CORP | Stock-Consumer Staples | 1.64% | +0.05% | — | |
| 25 | APO | Apollo Global Management Inc | Stock-Financials | 1.61% | -0.27% | +25.88% | |
| 26 | MSFT | Microsoft CORP | Stock-Tech | 1.58% | -0.02% | +45.90% | |
| 27 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 1.58% | -2.45% | EXIT | |
| 28 | CMPX | Compass Therapeutics Inc | Stock-Other | 1.56% | -1.37% | +0.58% | |
| 29 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 1.52% | -1.04% | +21.93% | |
| 30 | NOW | Servicenow Inc | Stock-Tech | 1.22% | — | +1670.20% | |
| 31 | DHR | Danaher CORP | Stock-Healthcare | 1.15% | -0.09% | -4.50% | |
| 32 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 1.14% | -0.97% | -27.83% | |
| 33 | ERAS | Erasca Inc | Stock-Other | 1.11% | -1.42% | EXIT | |
| 34 | CRM | Salesforce Inc | Stock-Tech | 1.08% | — | +59.60% | |
| 35 | GLUE | Monte Rosa Therapeutics Inc | Stock-Other | 1.08% | -0.21% | — | |
| 36 | CAPR | Capricor Therapeutics Inc | Stock-Other | 1.06% | -1.16% | — | |
| 37 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.95% | — | — | |
| 38 | ORCL | Oracle CORP | Stock-Tech | 0.90% | — | — | |
| 39 | MGM | Mgm Resorts International | Stock-Consumer Disc | 0.90% | -0.01% | — | |
| 40 | COF | Capital One Financial CORP | Stock-Financials | 0.85% | -0.19% | -27.98% | |
| 41 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.84% | -0.05% | EXIT | |
| 42 | MSOS | Advisorshares Pure US Cann | ETF-Other | 0.84% | +0.08% | +20.97% | |
| 43 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.75% | -0.21% | +15.69% | |
| 44 | FERG | Ferguson Enterprises Inc | Stock-Industrials | 0.73% | -0.19% | -48.02% | |
| 45 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.69% | -0.09% | — | |
| 46 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.67% | -0.10% | +65.19% | |
| 47 | ✓ | Zura Bio LTD | Stock-Other | 0.60% | -0.36% | +1.72% | |
| 48 | QURE | uniQure N.V. | Stock-Other | 0.60% | — | — | |
| 49 | PROK | Prokidney CORP | Stock-Other | 0.57% | -0.10% | — | |
| 50 | COHR | Coherent CORP | Stock-Tech | 0.52% | -0.18% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ARQT | Arcutis Biotherapeutics Inc | +2.1% | +14.18% | Add |
| 2 | RCUS | Arcus Biosciences Inc | +1.3% | +40.66% | Add |
| 3 | NOW | Servicenow Inc | +0.7% | +1670.20% | Add |
| 4 | AMZN | Amazon.com Inc | +0.7% | +85.84% | Add |
| 5 | EYPT | Eyepoint Inc | +0.7% | +26.40% | Add |
| 6 | PVLA | Palvella Therapeutics Inc | +0.6% | +8.51% | Add |
| 7 | APLSUSD | Apellis Pharmaceuticals Inc | +0.5% | +43.83% | Add |
| 8 | GLUE | Monte Rosa Therapeutics Inc | +0.4% | — | Unchanged |
| 9 | CRM | Salesforce Inc | +0.3% | +59.60% | Add |
| 10 | CMPX | Compass Therapeutics Inc | +0.3% | +0.58% | Add |
| 11 | ERAS | Erasca Inc | +0.3% | — | Unchanged |
| 12 | FULC | Fulcrum Therapeutics Inc | +0.3% | +21.93% | Add |
| 13 | BHVN | Biohaven Ltd. | +0.2% | +83.03% | Add |
| 14 | BAC | Bank Of America CORP | +0.2% | +30.79% | Add |
| 15 | CTNM | Contineum Therapeutics Inc-a | +0.2% | +65.19% | Add |
| 16 | APO | Apollo Global Management Inc | +0.1% | +25.88% | Add |
| 17 | MSFT | Microsoft CORP | +0.1% | +45.90% | Add |
| 18 | 4XC1 | Kalvista Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 19 | EXK | Exact Sciences CORP | +0.1% | — | Unchanged |
| 20 | AMD | Advanced Micro Devices | +0.1% | -2.31% | Trim |
| 21 | 2KZ0 | Kezar Life Sciences Inc | 0% | — | Unchanged |
| 22 | NTRA | Natera Inc | 0% | — | Unchanged |
| 23 | WHWK | Whitehawk Therapeutics Inc | — | — | Unchanged |
| 24 | ISRG | Intuitive Surgical Inc | — | — | Unchanged |
| 25 | MTD | Mettler-toledo International | — | — | Unchanged |
| 26 | IQV | Iqvia Holdings Inc | — | — | Unchanged |
| 27 | WAT | Waters CORP | — | — | Unchanged |
| 28 | IONS | Ionis Pharmaceuticals Inc | — | — | Unchanged |
| 29 | HCA | Hca Healthcare Inc | — | — | Unchanged |
| 30 | EW | Edwards Lifesciences CORP | — | — | Unchanged |
| 31 | SRPT | Sarepta Therapeutics Inc | — | — | Unchanged |
| 32 | VLTO | Veralto CORP | — | — | Unchanged |
| 33 | ZBH | Zimmer Biomet Holdings Inc | — | — | Unchanged |
| 34 | STE | STERIS plc | — | — | Unchanged |
| 35 | KURA | Kura Oncology Inc | 0% | +5.66% | Add |
| 36 | ✓ | Zura Bio LTD | 0% | +1.72% | Add |
| 37 | MOLN | Molecular Partners AG -adr | 0% | — | Unchanged |
| 38 | TMO | Thermo Fisher Scientific Inc | 0% | — | Unchanged |
| 39 | UTHR | United Therapeutics CORP | 0% | — | Unchanged |
| 40 | COR | Cencora Inc | 0% | — | Unchanged |
| 41 | MCK | Mckesson CORP | 0% | — | Unchanged |
| 42 | RMD | Resmed Inc | 0% | — | Unchanged |
| 43 | A | Agilent Technologies Inc | 0% | — | Unchanged |
| 44 | DXCM | Dexcom Inc | 0% | — | Unchanged |
| 45 | MDT | Medtronic plc | 0% | — | Unchanged |
| 46 | SYK | Stryker CORP | 0% | — | Unchanged |
| 47 | MSOS | Advisorshares Pure US Cann | 0% | +20.97% | Add |
| 48 | ABT | Abbott Laboratories | 0% | — | Unchanged |
| 49 | AVBP | Arrivent Biopharma Inc | -0.1% | +10.87% | Add |
| 50 | GS | Goldman Sachs Group Inc | -0.1% | — | Unchanged |
According to official SEC Form 13F filings, Montanova Capital, LLC reported a total U.S. public equity portfolio value of $5.5B across 93 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, ARQT, ARKG) accounted for 26.2% of total reported equity market value during Q4 2025.
Top New Position Initiated
ARKG
市值: $241.7M
Top Position Liquidated / Trimmed
ETNBGBP
前期市值: $121.7M
During Q4 2025, Montanova Capital, LLC's top holdings by market value included SPY (11.2%)、ARQT (7.1%)、ARKG (5.0%). The largest single position, SPY, represented 11.2% of total portfolio value.
In Q4 2025, Montanova Capital, LLC made 68 total portfolio adjustments, initiating 15 new buys, adding to 25 positions, trimming 14 holdings, and fully liquidating 14 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.